Monday July

• The FDA’s Pharmacy Compounding Advisory Committee has approved the peptides epitalon and semax for compounding. • Medical experts warn that this decision may mislead the public into believing the FDA has thoroughly evaluated the safety and efficacy of these compounds. • Critics argue the move is significant because it could potentially undermine the integrity and future of the formal FDA drug approval process.

• Andy Burnham, the former mayor of Manchester, has officially taken over as the United Kingdom’s next prime minister. • Burnham succeeds Keir Starmer, who was forced to resign after the Labour Party suffered significant losses in recent local elections. • This transition marks the seventh time the UK has changed prime ministers within a single decade, highlighting ongoing political instability.

• Market experts are analyzing whether the Nifty will cross the 24,300 mark on Monday, July 13, amid supportive domestic fundamentals. • Immediate resistance is identified in the 24,400-24,600 zone, with a potential breakout potentially leading the index toward the 25,000 level. • While market breadth is improving, Ravi Singh of Master Capital warns that volatility may persist due to crude oil fluctuations and the resurfacing crisis in West Asia.